REG - Witan Inv Tst PLC - Director/PDMR Shareholding

Witan Investment TrustAnnouncement

13/03/2020 17:20

RNS Number : 1745G
  
Witan Investment Trust PLC
  
13 March 2020
  
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 
 


Andrew John Shirley Ross 




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 
 


Non-executive director  




b) 
 


Initial notification /Amendment 
 
 


Initial notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 
 


Witan Investment Trust plc




b) 
 


LEI 
 
 


213800XMW68XFT6D1X59




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code 
 
 


Ordinary shares of 5p each
 
 
GB00BJTRSD38
 




b) 
 


Nature of the transaction 
 
 


Acquisition of shares (dividend reinvestment)




c) 
 


Price(s) and volume(s) 
 
 


 



Price(s)
 


Volume(s)




164.513 pence per share
 


100,000
 



 
 




d) 
 


Aggregated information 
- Aggregated volume 
 
- Price 


 
100,000 ordinary 5p shares
 
164.513 pence per share




e) 
 


Date of the transaction 
 
 


13 March 2020




f) 
 


Place of the transaction 
 
 


London Stock Exchange (XLON)



 
Name of authorised official of issuer responsible for making notification:
 
Eleanor Cranmer, for and on behalf of Frostrow Capital LLP
Company Secretary to WITAN INVESTMENT TRUST PLC
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHSFMFWDESSEFD